Journal of Clinical Pediatrics >
Clinical and genetic analysis of Wiedemann-Steiner syndrome caused by KMT2A gene mutation in three cases
Received date: 2022-04-18
Online published: 2023-08-10
Objective To report the clinical and genetic characteristics of three cases of Wiedemann-Steiner syndrome (WDSTS) caused by KMT2A gene mutation, and improve the understanding of the disease and the efficiency of diagnosis and treatment. Methods The clinical data of three cases of WDSTS caused by KMT2A gene mutation in three families diagnosed in Shengjing Hospital of China Medical University from December 2019 to September 2021 were reviewed, and the clinical and genetic characteristics of WDSTS patients reported in the literature were reviewed and summarized. Results All three cases were diagnosed in infancy, with the youngest age of diagnosis of two months old, and the reasons for consultation were growth retardation and anorexia, respectively. Similar to those in previous literature, the clinical manifestations were special facial features, malnutrition (3/3), feeding difficulties, sleep disorders, hirsutism (2/3), and developmental delay (1/3). The clinical manifestations that had not been reported before were umbilical hernia and inguinal hernia. All three cases were de novo frameshift variants, which occurred in exon 3 and 27 in hot spot variants region and exon 11 in non-hot spot variants region, respectively. Conclusions Wiedemann-Steiner syndrome should be considered in children with malnutrition, feeding difficulty and developmental delay, combined with special facial features and specific hirsute. High-throughput exome sequencing should be used to facilitate early diagnosis. De novo frameshift variants of KMT2A gene are common, with hot spots in exon 27 and 3. The three unreported frameshift variants in this study enrich the mutation spectrum of this gene. In addition, patients with variants in the CXXC region of the KMT2A gene may have a more severe clinical phenotype.
Key words： malnutrition; feeding difficulty; Wiedemann-Steiner syndrome
Suying LIU , Fang LI , Hongwei MA . Clinical and genetic analysis of Wiedemann-Steiner syndrome caused by KMT2A gene mutation in three cases[J]. Journal of Clinical Pediatrics, 2023 , 41(8) : 618 -623 . DOI: 10.12372/jcp.2023.22e0472
| [1] | Li N, Wang Y, Yang Y, et al. Description of the molecular and phenotypic spectrum of Wiedemann-Steiner syndrome in Chinese patients[J]. Orphanet J Rare Dis, 2018, 13(1): 178. |
| [2] | Sheppard SE, Campbell IM, Harr MH, et al. Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome[J]. Am J Med Genet A, 2021, 185(6): 1649-1665. |
| [3] | Sheppard SE, Quintero-Rivera F. Wiedemann-Steiner Syndrome[M]. Adam MP, Everman DB, Mirzaa GM, et al. GeneReviews? [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. |
| [4] | 贝利婴幼儿发展量表在中国的修订与应用[Z]. 湖南长沙:中南大学湘雅二医院, 2001-01-01. |
| [5] | 黎海芪. 实用儿童保健学[M]. 北京: 人民卫生出版社, 2022. |
| [6] | Lebrun N, Giurgea I, Goldenberg A, et al. Molecular and cellular issues of KMT2A variants involved in Wiedemann-Steiner syndrome[J]. Eur J Hum Genet, 2018, 26(1): 107-116. |
| [7] | Luo S, Bi B, Zhang W, et al. Three de novo variants in KMT2A (MLL) identified by whole exome sequencing in patients with Wiedemann-Steiner syndrome[J]. Mol Genet Genomic Med, 2021, 9(10): e1798. |
| [8] | Feldman HR, Dlouhy SR, Lah MD, et al. The progression of Wiedemann-Steiner syndrome in adulthood and two novel variants in the KMT2A gene[J]. Am J Med Genet A, 2019, 179(2): 300-305. |
| [9] | Giangiobbe S, Caraffi SG, Ivanovski I, et al. Expanding the phenotype of Wiedemann-Steiner syndrome: Craniovertebral junction anomalies[J]. Am J Med Genet A, 2020, 182(12): 2877-2886. |
| [10] | Baer S, Afenjar A, Smol T, et al. Wiedemann-Steiner syndrome as a major cause of syndromic intellectual disability: A study of 33 French cases[J]. Clin Genet, 2018, 94(1): 141-152. |
| [11] | Li N, Wang Y, Yang Y, et al. Description of the molecular and phenotypic spectrum of Wiedemann-Steiner syndrome in Chinese patients[J]. Orphanet J Rare Dis, 2018, 13(1): 178. |
| [12] | 马岭, 徐庆吉, 胡艳艳. KMT2A基因新发突变导致Wiedemann-Steiner综合征合并矮身材1例[J]. 临床医学进展, 2021, 11(7): 2914-2919. |
| [13] | 上官华坤, 胡旭昀, 沈亦平, 等. KMT2A基因新突变导致Wiedemann-Steiner综合征1例并文献复习[J]. 中华内分泌代谢杂志, 2019, 35(1): 26-31. |
| [14] | Stoyle G, Banka S, Langley C, et al. Growth hormone deficiency as a cause for short stature in Wiedemann-Steiner Syndrome[J]. Endocrinol Diabetes Metab Case Rep, 2018: 18-0085. |
| [15] | Bogaert DJ, Dullaers M, Kuehn HS, et al. Early-onset primary antibody deficiency resembling common variable immunodeficiency challenges the diagnosis of Wiedeman-Steiner and Roifman syndromes[J]. Sci Rep, 2017, 7(1): 3702. |
| [16] | Jinxiu L, Shuimei L, Ming X, et al. Wiedemann-steiner syndrome with a de novo mutation in KMT2A: A case report[J]. Medicine (Baltimore), 2020, 99(16): e19813. |
| [17] | Ramirez-Montano D, Pachajoa H. Wiedemann-Steiner syndrome with a novel pathogenic variant in KMT2A: a case report[J]. Colomb Med (Cali), 2019, 50(1): 40-45. |
| [18] | Hirst L, Evans R. Wiedemann-Steiner syndrome: A case report[J]. Clin Case Rep, 2021, 9(3): 1158-1162. |
| [19] | Arora V, Puri RD, Bijarnia-Mahay S, et al. Expanding the phenotypic and genotypic spectrum of Wiedemann-Steiner syndrome: first patient from India[J]. Am J Med Genet A, 2020, 182(5): 953-956. |
| [20] | Demir S, Gurkan H, Oz V, et al. Wiedemann-Steiner syndrome as a differential diagnosis of cornelia de lange syndrome using targeted next-generation sequencing: a case report[J]. Mol Syndromol, 2021, 12(1): 46-51. |
| [21] | Chen M, Liu R, Wu C, et al. A novel de novo mutation (p.Pro1310Glnfs*46) in KMT2A caused Wiedemann-Steiner Syndrome in a Chinese boy with postnatal growth retardation: a case report[J]. Mol Biol Rep, 2019, 46(5): 5555-5559. |
| [22] | Wang X, Zhang G, Lu Y, et al. Trio-WES reveals a novel de novo missense mutation of KMT2A in a Chinese patient with Wiedemann-Steiner syndrome: A case report[J]. Mol Genet Genomic Med, 2021, 9(1): e1533. |
| [23] | Matis T, Michaud V, Van-Gils J, et al. Triple diagnosis of Wiedemann-Steiner, Waardenburg and DLG3-related intellectual disability association found by WES: A case report[J]. J Gene Med, 2020, 22(8): e3197. |
| [24] | Chan A, Cytrynbaum C, Hoang N, et al. Expanding the neurodevelopmental phenotypes of individuals with de novo KMT2A variants[J]. NPJ Genom Med, 2019, 4: 9. |
| [25] | 薛慧琴, 冯宇, 张钏, 等. KMT2A基因新发无义变异导致Wiedemann-Steiner综合征一例[J]. 中华医学遗传学杂志, 2021, 38(2): 138-140. |
| [26] | 王嘉丽, 黄轲, 吴蔚, 等. KMT2A基因新发变异引起的 Wiedemann-Steiner 综合征一例[J]. 中华儿科杂志, 2021, 59(6): 516-518. |
| [27] | 代丽芳, 方方, 田小娟, 等. KMT2A基因变异导致儿童Wiedemann-Steiner综合征1例[J]. 中华实用儿科临床杂志, 2019, 34(13): 1027-1029. |
| [28] | Lee CL, Chuang CK, Chiu HC, et al. Wiedemann-Steiner syndrome with a pathogenic variant in KMT2A from Taiwan[J]. Children (Basel), 2021, 8(11): 952. |
| [29] | Nardello R, Mangano GD, Fontana A, et al. Broad neurodevelopmental features and cortical anomalies associated with a novel de novo KMT2A variant in Wiedemann-Steiner syndrome[J]. Eur J Med Genet, 2021, 64(2): 104133. |
| [30] | Di Fede E, Massa V, Augello B, et al. Expanding the phenotype associated to KMT2A variants: overlapping clinical signs between Wiedemann-Steiner and Rubinstein-Taybi syndromes[J]. Eur J Hum Genet, 2021, 29(1): 88-98. |
| [31] | Negri G, Magini P, Milani D, et al. Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: the interconnections of epigenetic machinery disorders[J]. Hum Genet, 2019, 138(3): 257-269. |
| [32] | Gao ZJ, Jiang Q, Chen XL, et al. Study of de novo point mutations in known genes among patients with unexplained intellectual disability or developmental delay[J]. Zhonghua Yi Xue Za Zhi, 2018, 98(42): 3426-3432. |
| [33] | Zhang H, Xiang B, Chen H, et al. A novel deletion mutation in KMT2A identified in a child with ID/DD and blood eosinophilia[J]. BMC Med Genet, 2019, 20(1): 38. |
| [34] | Jezela-Stanek A, Ciara E, Jurkiewicz D, et al. The phenotype-driven computational analysis yields clinical diagnosis for patients with atypical manifestations of known intellectual disability syndromes[J]. Mol Genet Genomic Med, 2020, 8(9): e1263. |
| [35] | Grangeia A, Leao M, Moura CP. Wiedemann-Steiner syndrome in two patients from Portugal[J]. Am J Med Genet A, 2020, 182(1): 25-28. |
| [36] | Mietton L, Lebrun N, Giurgea I, et al. RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome[J]. Neuromolecular Med, 2018, 20(3): 409-417. |
/
| 〈 |
|
〉 |
